Semaglutide and Liver Enzymes: What You Should Know

You've just seen your liver results and started wondering about Wegovy

It's a position a lot of people find themselves in. Maybe the abnormal range was already there on last year's test, maybe it appeared after starting treatment, or maybe your GP spotted it at a routine check and suggested you look into whether the injection could be responsible. The honest answer takes a few parts.

Liver enzymes (ALT, AST, GGT and ALP are the ones most commonly flagged) rise when liver cells are under stress. Semaglutide, which works partly by slowing gastric emptying and reducing appetite, does not appear to directly damage liver tissue. In the large STEP 1 trial published in the New England Journal of Medicine, semaglutide 2.4mg over 68 weeks produced significant weight reduction without a signal of hepatotoxicity in participants. That is reassuring background, but the word "appear" matters here, because individual responses vary and confounding factors are real.

Rapid weight loss itself can sometimes temporarily shift liver enzyme readings, particularly ALT, as fat leaves the liver during the early months of treatment. This settles in most people. If your results were raised before starting, the cause is likely pre-existing and unrelated to Wegovy, what semaglutide does to the liver in that context is a slightly different question, and one worth reading about separately.

When raised enzymes on Wegovy are worth acting on quickly

Mild, transient elevations (say, ALT a little above the reference range on one test but trending down) are rarely a reason to stop treatment without a prescriber's input. Persistent, worsening or significantly raised enzymes (sometimes described as more than three times the upper limit of normal) are different and need medical review promptly.

Gallbladder problems are one reason to act quickly. GLP-1 medicines including semaglutide are associated with a modestly increased risk of gallstones and gallbladder inflammation, partly because of rapid weight loss. Gallbladder disease can raise liver enzymes. If you also have upper-right abdominal pain, nausea or a fever, seek medical advice the same day rather than waiting for a routine appointment. The NHS medicines page for semaglutide lists the symptoms that need urgent attention.

Other causes to rule out: alcohol intake (which can be easy to overlook), other prescription or over-the-counter medicines, thyroid conditions and viral hepatitis. None of these are caused by semaglutide, but they can be masked by an assumption that the injection is responsible. A prescriber needs the full list of what you're taking. Our clinical team reviews medication history as part of every consultation for precisely this reason.

Semaglutide and fatty liver disease: what the MASH approval means in practice

This is where the evidence gets genuinely interesting, and where Wegovy liver enzymes take on a different meaning. Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive form of fatty liver disease that can lead to cirrhosis. On 3 July 2026, the MHRA granted conditional approval for semaglutide (Wegovy) to treat adults with MASH accompanied by moderate-to-advanced liver fibrosis, as announced on GOV.UK. This makes it the first GLP-1 receptor agonist to hold a UK licence for a liver condition.

What this tells us in practical terms: in the trial populations that supported this approval, semaglutide was associated with reductions in liver inflammation and fibrosis markers, and liver enzyme levels including ALT often fell alongside bodyweight. For someone with obesity and elevated liver enzymes driven by fatty liver, you can read about how Wegovy affects liver enzymes to understand whether the medicine may be addressing part of the underlying problem rather than adding to it.

That said, the MASH indication is a specialist one. nume prescribes Wegovy for weight management; whether a patient's liver profile makes them a candidate for MASH-specific treatment is a decision for a hepatologist or gastroenterologist. If you have been told you have significant fibrosis, ask your specialist about this approval specifically. You can explore the full picture of how Wegovy interacts with the liver for a more detailed look at the underlying mechanism.

How to handle this conversation with your prescriber or GP

Bring the actual numbers. A printout or screenshot of your liver function test results (with dates and reference ranges) is far more useful than a description. Note when you started Wegovy, which dose you're on, any other medicines you take (including supplements and herbal products), and your average weekly alcohol intake. That's the picture a prescriber needs.

At nume, a real clinician reviews your consultation (not automated software) and that includes your medication list and any relevant medical history you share. If raised liver enzymes come up during treatment, it helps to understand whether Wegovy can cause high liver enzymes before the conversation with your prescriber, so you and your GP can work through it in parallel rather than starting from scratch. Semaglutide is a prescription medicine and its continuation through a liver enzyme query is a clinical call, not one to make alone based on what you read online.

If you're weighing up whether Wegovy is right for you given your liver history, reading about whether semaglutide causes elevated liver enzymes alongside how Wegovy works gives a useful combined picture. When you're ready to speak to a prescriber directly, starting a free consultation is the straightforward next step.